
Family blames Denver Housing Authority for senior's death in sweltering apartment
Shirlyne Johnson
Johnson Family
Shirlyne Johnson, 68, was found dead two years ago inside her unit on the sixth floor of Thomas Bean Towers -- a public housing complex for seniors in Denver. According to the lawsuit, the temperature inside her apartment exceeded 120 degrees.
Her daughter, Latrisse Johnson, says the family still struggles to process the loss.
"I was not able to see my mother when we did funeral services," she said. "She was decomposed."
The lawsuit alleges that Johnson, who had pre-existing health conditions, had repeatedly requested maintenance to fix her malfunctioning HVAC system, which was reportedly pumping hot air into her apartment for days, according to the lawsuit.
"Her complaint was, 'My AC is not working,' and if they had just taken the time to go and see what the issue was, I think it could've saved my mom's life," Latrisse said.
CBS
The Denver Housing Authority manages the Thomas Bean Towers. The lawsuit claims the agency failed to respond to maintenance requests in a timely and appropriate manner, ultimately leading to Johnson's death.
The autopsy report, cited in the lawsuit, found multiple contributing factors in Johnson's death, which were "complicated by exposure to an increased environmental temperature." Her body temperature was recorded at 111 degrees at the time of death.
"It could've been an easy fix," Latrisse said. "I need the Denver Housing Authority to be accountable for their actions. I don't want any other residents or disabled elderly to go through what my mom went through."
In a statement to CBS News Colorado, the Denver Housing Authority said:
"While we are unable to comment at this time due to the open court case, our mission remains focused on providing safe, stable housing and supporting the communities we serve."
Latrisse Johnson says that statement does not reflect her family's experience.
"The housing authority needs to do better," she said.
A judge will now decide whether the lawsuit can move forward or if DHA is protected under Colorado's Governmental Immunity Act. That ruling could take several months.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
The Oncology Institute Announces Changes to Board of Directors
Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ('TOI') (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Richard Barasch will retire from his role as Chairman of the Board, effective August 12, 2025. Anne McGeorge, who currently serves as a Board Member and Chair of the Audit Committee, will succeed Barasch in the role. 'We are thrilled to have Anne McGeorge serve as our next Chairman of the Board,' said Daniel Virnich, MD, CEO of The Oncology Institute. 'Having worked with Anne since she joined The Oncology Institute's board in 2021, I feel confident that she is the right person for the job. Her extensive experience in providing strategic guidance to management teams, deep knowledge of the healthcare space and proven financial acumen have been greatly beneficial to The Oncology Institute thus far and we look forward to working even more closely with her as she takes on this leadership role.' Ms. McGeorge brings over 35 years of experience as a trusted operational and financial advisor to healthcare organizations. Before retiring in 2017, she helped launch Grant Thornton LLP's Global Health Care and Life Sciences Practice and served as the managing partner for 10 years, growing it into a $250 million global business during her time in the position. Earlier in her career, she was a partner at both Deloitte and Arthur Andersen and an adjunct professor at the University of North Carolina School of Public Health. Currently, Ms. McGeorge serves on the board of directors and as the chair of the Audit Committee of Dianthus Therapeutics (NASDAQ: DNTH), a clinical-stage biotechnology company, Nimbus Therapeutics and CitiusTech, both privately held healthcare companies, CLEAR Insurance, a Cayman based Captive Insurance Company, and the William and Mary Business School Foundation. She holds an MS degree in Accounting from the University of Virginia and a BBA degree in Accounting from William & Mary. "I am honored to serve as Chairman and look forward to working with the board and management team to continue advancing our mission of providing exceptional oncology care," said Ms. McGeorge. Dr. Virnich added, "We thank Richard for his outstanding leadership and dedication to The Oncology Institute. Under his guidance, we became a publicly traded company, strengthened our management team, and we were able to prove our business model and value to payors outside of California. The leadership that he brought to our Board and the organization as a whole will have a lasting impact.' Mr. Richard Barasch said, 'Having been with The Oncology Institute since it became a public company, I have had the privilege of getting to know this impressive mission-driven organization, so capably led by CEO Dan Virnich. Anne McGeorge is the best candidate to take over my role as Chairman, and I look forward to seeing the contributions she will surely make with her impressive experience and skillset.' About The Oncology Institute Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better. For more information, visit Contacts Media The Oncology Institute, Investors ICR HealthcareTOI@ in to access your portfolio


Washington Post
3 minutes ago
- Washington Post
Cowboys owner Jerry Jones reveals cancer diagnosis and credits experimental drug
OXNARD, Calif. — Dallas Cowboys owner Jerry Jones credited an experimental trial drug for successfully treating advanced melanoma as he disclosed his cancer diagnosis publicly for the first time. Jones revealed his illness in a documentary, 'America's Team: The Gambler and His Cowboys,' which will debut on Netflix next week. The 82-year-old Jones then told The Dallas Morning News how he was initially diagnosed in June 2010 and underwent two surgeries on his lung and two on his lymph nodes over the next 10 years after skin cancer cells metastasized to other parts of his body.


Fox News
3 minutes ago
- Fox News
NIH director discusses mRNA technology and funding
Fox News senior medical analyst Dr. Marc Siegel reveals what he learned from his interview with National Institutes of Health director Jay Bhattacharya on 'America Reports.'